Figure 3.
Changes in body weight and blood glucose levels in HFD/STZ-induced diabetic model rats
(A) Body weight changes in control rats and HFD/STZ-induced diabetic model rats were not significant.
(B) After STZ injection, the blood glucose concentration in the HFD/STZ group was significantly greater than that in the control group on day 28.
(C) Fasting blood glucose levels in the control group and HFD/STZ group. The fasting blood glucose level in the HFD/STZ group was significantly greater than that in the control group.
(D) According to the insulin tolerance test, HFD/STZ model rats were not sensitive to insulin and showed insulin resistance.
(E) According to the glucose tolerance test, blood glucose levels in the HFD/STZ group were greater than those in the control group.
(F) The area under the curve (AUC) for the glucose tolerance test was significantly greater in the HFD/STZ group than in the control group. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 (n = 8 in each group). Data are represented as mean ± SD.
